In fact, various tumor suppressor genes, such as p21Cip1, p16Ink4a, p15Ink4b and p19Arf were up-regulated in sarcomas of RGKO-p53 mice, thus offering novel opportunities for the development of synthetic lethal therapeutic approaches. This evidence concerns the gene TP53 and sarcoma.